(Q34232039)

31 July 2017

1 reference

title

Novel approaches to the treatment of chronic graft-versus-host disease (English)

1 reference

31 July 2017

D Gaziev

1

1 reference

31 July 2017

G Lucarelli

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Expert Opinion on Investigational Drugs

31 July 2017

published in

1 reference

31 July 2017

volume

10

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

909-923

1 reference

Bone marrow transplantation in patients with thalassemia

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Graft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

A three or more drug combination as effective therapy for moderate or severe chronic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Chronic graft-versus-host disease: is there an alternative to the conventional treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

The potential use of thalidomide in the therapy of graft-versus-host disease--a review of clinical and laboratory information

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Photochemistry and photobiology of psoralens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Photopheresis: clinical applications and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Extracorporeal photochemotherapy in the treatment of severe graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Clinical pharmacokinetics of clofazimine. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Clofazimine in the treatment of discoid lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Clofazimine in the treatment of annular lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Treatment of pustular psoriasis with clofazimine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Infection in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Reimmunization after blood or marrow stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Long-term cyclosporin therapy may decrease the risk of chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Nedocromil sodium ameliorates skin manifestations in a murine model of chronic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.5.909

10.1517/13543784.10.5.909

21 January 2018

Identifiers

DOI

1 reference

release_3gso3jozbjb7lnq7kxoym3whhm

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3gso3jozbjb7lnq7kxoym3whhm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference